Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data

被引：31
作者：
Bodnarczyk, Robert A. [1 ,2 ,3 ,4 ]
Ellingson, Mallory K. [1 ]
Omer, Sead B. [1 ,2 ,3 ,5 ]
机构：
[1] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, CNR 7019,Mailstop 1518-002-7BB,1518 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Winship Canc Inst, Canc Prevent & Control Program, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2019年 / 220卷 / 05期
关键词：
HPV; human papillomavirus; vaccination; immunization; UNITED-STATES; ADVISORY-COMMITTEE; VIRGINITY; SCHEDULE;
D O I：
10.1093/infdis/jiy682
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Human papillomavirus (HPV) vaccination is suboptimally used in the United States. Vaccination before the 13th birthday is recommended by the Advisory Committee on Immunization Practices and vaccination before the 15th birthday requires only 2 doses. We estimated the proportion of adolescents up to date for HPV vaccine using provider-verified vaccination data from the 2016 National Immunization Survey-Teen. Only 16% of US adolescents completed HPV vaccination before turning 13, and 35% completed HPV vaccination before turning 15. With sexual activity initiation increasing throughout adolescence and higher immunogenicity for younger vaccinees, vaccination before the 13th birthday can provide better protection against HPV-related cancers.
引用
收藏
页码：730 / 734
页数：5
相关论文
共 14 条
  • [1] [Anonymous], 2017, NATL HLTH STAT REPOR
  • [2] Defining virginity and abstinence: Adolescents' interpretations of sexual behaviors
    Bersamin, Melina M.
    Fisher, Deborah A.
    Walker, Samantha
    Hill, Douglas L.
    Grube, Joel W.
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2007, 41 (02) : 182 - 188
  • [3] Center for Sexual Health Promotion, 2010, PERC AM PERF CERT SE
  • [4] Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases, 2017, NAT IMM SURV TEEN US
  • [5] Czajka John L., 2016, Technical Report Final Report, VI
  • [6] Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007-2014
    Gargano, Julia W.
    Zhou, Fangjun
    Stokley, Shannon
    Markowitz, Lauri E.
    [J]. VACCINE, 2018, 36 (23) : 3381 - 3386
  • [7] Youth Risk Behavior Surveillance - United States, 2017
    Kann, Laura
    McManus, Tim
    Harris, William A.
    Shanklin, Shari L.
    Flint, Katherine H.
    Queen, Barbara
    Lowry, Richard
    Chyen, David
    Whittle, Lisa
    Thornton, Jemekia
    Lim, Connie
    Bradford, Denise
    Yamakawa, Yoshimi
    Leon, Michelle
    Brener, Nancy
    Ethier, Kathleen A.
    [J]. MMWR SURVEILLANCE SUMMARIES, 2018, 67 (08): : 1 - 114
  • [8] Penises not required: a systematic review of the potential for human papillomavirus horizontal transmission that is non-sexual or does not include penile penetration
    Liu, Zhiyue
    Rashid, Tasnuva
    Nyitray, Alan G.
    [J]. SEXUAL HEALTH, 2016, 13 (01) : 10 - 21
  • [9] Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices
    Meites, Elissa
    Kempe, Allison
    Markowitz, Lauri E.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (49): : 1405 - 1408
  • [10] Operationalizing outcome measures of human papillomavirus vaccination among adolescents
    Odoh, C.
    Sanderson, M.
    Williams, E. A.
    Hull, P. C.
    [J]. PUBLIC HEALTH, 2018, 159 : 129 - 132
12